- The diet is known to control hypertension, diabetes, gout and kidney disease and was named the best diet for the 8th year in a row by US News & World Report.
- Controlling gout may be as simple as following a healthier diet full of fruits and veggies, and lacking red meat and sweets.
- Eating Kerson fruit may alleviate health conditions, from diabetes to gastric ulcers.
- If AstraZeneca's drug is approved, it will be the first in 60 years to address inefficient excretion in gout patients.
- Supplementation with vitamin C doesn't do much to lower uric acid levels in people who already have gout, researchers say.
- Cherries lower gout attack risk by 35 percent alone and up to 75 percent if consumed while following standard gout treatment, says a new study.
- Even relatively low levels of lead in the blood may be linked to an increased risk of gout, a painful form of arthritis.
- A Brazilian hospital-based study assessed responses to flu vaccines in 340 RA patients in regular follow-up compared to 234 healthy patients. Measures of protection obtained by vaccination (seroprotection rate (SP)) after immunization was over 20% lower for RA patients compared to healthy individuals (60.1% vs. 82.9% comparatively (p
- In a new research presented at the American College of Rheumatology Annual Scientific Meeting in Atlanta, it showed that women drinking more than one serving of sugary soda or orange juice per day are at an increased risk for developing gout as they grow older.
- Consumption of fructose-rich beverages, such as sugar-sweetened sodas and orange juice is associated with an increased risk of gout among women, although their contribution to the risk of gout in the population is likely modest because of the low incidence rate among women, according to a study that will appear in the November 24 print edition of JAMA.
- Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
- The U.S. Food and Drug Administration today approved Krystexxa (pegloticase) to treat the painful condition known as gout in adults who do not respond to or who cannot tolerate conventional therapy.
Gout is a condition usually characterized by recurrent attacks of acute inflammatory arthritis—a red, tender, hot, swollen joint. The metatarsal-phalangeal joint at the base of the big toe is the most commonly affected. However, it may also present as tophi, kidney stones, or urate nephropathy. It is caused by elevated levels of uric acid in the blood which crystallizes and the crystals are deposited in joints, tendons, and surrounding tissues.